Aadi Bioscience Inc (AADI)
1.68
-0.10
(-5.62%)
USD |
NASDAQ |
Apr 25, 16:00
1.675
0.00 (0.00%)
After-Hours: 20:00
Aadi Bioscience Shareholders Equity (Quarterly): 105.20M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 105.20M |
| September 30, 2023 | 118.20M |
| June 30, 2023 | 131.42M |
| March 31, 2023 | 145.99M |
| December 31, 2022 | 158.38M |
| September 30, 2022 | 169.11M |
| Date | Value |
|---|---|
| June 30, 2022 | 108.73M |
| March 31, 2022 | 124.63M |
| December 31, 2021 | 136.41M |
| September 30, 2021 | 150.92M |
| December 31, 2020 | -12.43M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-12.43M
Minimum
Dec 2020
169.11M
Maximum
Sep 2022
121.50M
Average
131.42M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -106.49M |
| 89bio Inc | 536.31M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.42M |
| Total Liabilities (Quarterly) | 27.23M |
| Current Ratio | 4.720 |